Ancora Advisors, LLC
- SEC CIK
- 0001446114
- Latest filing
- Aug 14, 2026
OTLK holding history
Outlook Therapeutics, Inc. in every 13F filed by Ancora Advisors, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
OTLK overviewAll 13F holders of OTLKFull Q2 2026 holdings
- Shares (Q2 2026)
- 1,100
- Value
- $1.75K
- % of portfolio
- <0.1%
- Quarters held
- 17
- Since Q2 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 1,100 | $1.75K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2026 | 1,100 | $226 | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2025 | 1,100 | $1.74K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2025 | 1,100 | $1.17K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2025 | 1,100 | $1.76K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2025 | 1,100 | $1.34K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2024 | 1,100 | $2.08K | <0.1% | −5,000−82.0% | Reduced | Holders |
| Q3 2024 | 6,100 | $32.6K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2024 | 6,100 | $45.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2024 | 6,100 | $72.8K | <0.1% | 00.0% | UnchangedConverted for a 1-for-20 split | Holders |
| Q4 2023 | 122,000 | $48.1K | <0.1% | +100,000+454.5% | Added | Holders |
| Q3 2023 | 22,000 | $4.86K | <0.1% | −86,500−79.7% | Reduced | Holders |
| Q2 2023 | 108,500 | $188.8K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2023 | 108,500 | $118.3K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2022 | 108,500 | $117.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2022 | 108,500 | $132.0K | <0.1% | +86,500+393.2% | Added | Holders |
| Q2 2022 | 22,000 | $22.0K | <0.1% | +22,000 | New | Holders |